Gut microbiota mediates positive effects of liraglutide on dyslipidemia in mice fed a high-fat diet.
腸道菌群在高脂飲食小鼠中介導利拉魯肽對血脂異常的正面效應。
Front Nutr 2023-01-17
Phosphorylated proteomics-based analysis of the effects of semaglutide on hippocampi of high-fat diet-induced-obese mice.
Semaglutide對高脂飲食誘導肥胖小鼠海馬迴的磷酸化蛋白質組學分析。
Diabetol Metab Syndr 2023-04-03
Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice.
Semaglutide和empagliflozin對肥胖小鼠認知功能和海馬磷蛋白質組學的影響。
Front Pharmacol 2023-04-04
Effects of Glucagon-Like Peptide-1 Receptor Agonists on Gut Microbiota in Dehydroepiandrosterone-Induced Polycystic Ovary Syndrome Mice: Compared Evaluation of Liraglutide and Semaglutide Intervention.
GLP-1受體激動劑對去氫表雄酮誘導的多囊卵巢綜合症小鼠腸道菌叢的影響:利拉魯肽和塞麥魯肽干預的比較評估。
Diabetes Metab Syndr Obes 2024-02-27
Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease.
Semaglutide 改善肥胖和第二型糖尿病小鼠代謝功能障礙相關脂肪肝疾病中的肝部脂肪堆積和新生脂肪生成標誌。
Int J Mol Sci 2024-03-15
Semaglutide Attenuates Anxious and Depressive-Like Behaviors and Reverses the Cognitive Impairment in a Type 2 Diabetes Mellitus Mouse Model Via the Microbiota-Gut-Brain Axis.
Semaglutide 減輕焦慮和抑鬱樣行為,並通過微生物-腸-大腦軸逆轉 2 型糖尿病小鼠模型中的認知障礙。
J Neuroimmune Pharmacol 2024-07-23
Principal components analysis on genes related to inflammasome complex and microglial activation in the hypothalamus of obese mice treated with semaglutide (GLP-1 analog).
在接受semaglutide(GLP-1 類似物)治療的肥胖小鼠下丘腦中,與炎症小體複合體和小膠質細胞活化相關基因的主成分分析。
Brain Res 2024-09-07